Description and Brand Names

Drug information provided by: Merative, Micromedex®

US Brand Name

  1. Rybrevant


Amivantamab-vmjw injection is used alone to treat non-small cell lung cancer (NSCLC) that has spread (metastatic) or cannot be removed by surgery or radiation (locally advanced) in patients who have an abnormal epidermal growth factor receptor (EGFR) gene (exon 20 insertion mutations) and have received other cancer medicines (eg, platinum) but did not work well. This medicine is also used in combination with carboplatin and pemetrexed as a first-line treatment for metastatic or locally advanced NSCLC in patients who have an abnormal EGFR gene (exon 20 insertion mutations). Your doctor will perform a test before you take this medicine.

This medicine is to be given only by or under the supervision of your doctor.

This product is available in the following dosage forms:

  • Solution